Abstract CT257: First-in-human phase 1 studies of PTPN2/1 inhibitors ABBV-CLS-484 and ABBV-CLS-579 in locally advanced or metastatic tumors
Year: 2023
Type: conference-abstract
Source: Cancer Research
Authors: Patricia M. LoRusso, Emiliano Calvo Aller, Noboru Yamamoto, Chia-Chi Lin, Thaddeus Beck, David Sommerhalder, Do-Youn Oh, John D. Powderly, Talia Golan, Linu Sara Abraham, Joel S. Hayflick, Tamar Uziel, Priya Brunsdon, Wijith Munasinghe, Marcia Paddock, Cathleen Brdlik Hartman, Jonathan Powell, Bruno Medeiros, Martha R. Neagu, Benedito A. Carneiro
Institutions: Yale University, National Cancer Center Hospital, National Taiwan University Hospital, Seoul National University, Seoul National University Hospital, Carolina BioOncology Institute, Tel Aviv University, Sheba Medical Center, AbbVie (United States), Calico Life Sciences, Brown University, Lifespan
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4365512239